Ligand to Participate in Four Upcoming Investor Conferences
Ligand Provides Highlights from Today’s Analyst Day Event
Ligand Sells Promacta Assets and Royalty for $827 Million
Reminder: Ligand to Host Analyst Day on March 12th in New York City
Ligand Reports Fourth Quarter and Full Year 2018 Financial Results
Ligand Announces OmniAb® Partnership with Genagon Therapeutics
Ligand Announces Investment in Dianomi Therapeutics
Ligand Partner Seelos Therapeutics Becomes a Public Company
Ligand to Report Fourth Quarter and Full Year 2018 Results on February 7th
